BCR-ABL tyrosine kinase inhibitor (TKI)-induced nephropathy: An under-recognized phenomenon

摘要

Lab values from Case 1 and 2 while on BCR-ABL TKI and after discontinuation. (A) Graph depicting protein levels in the urine of case 1 increasing over time while on dasatinib and rapidly resolving after discontinuation. (B) Graph depicting the serum creatinine levels in case 2 increasing over time while on ponatinib and then normalizing after discontinuation.